
Unlocking the Power of Trilaciclib: Boosting Memory T-Cells for Stronger Immune Surveillance and Efficacy in Tumor Microenvironments
Phase 2 Mechanism of Action Trial Results Demonstrate the Immunomodulatory Effects of Trilaciclib in the Tumor Microenvironment Trilaciclib Enhances Expression of Genes Associated with Memory T Cells In a recent phase 2 clinical trial, the results have shown promising effects of Trilaciclib in modulating the tumor microenvironment. Trilaciclib, a novel drug, has been found to…